Pregmune Launches IRMA – A Comprehensive Reproductive Immunology Assessment

We’d love to thank everyone who showed up to the IRMA launch event on April 27^th at Blender Workspace. It was a memorable night. For those of you who couldn’t join us, don’t worry, we’ll hold more fun and informative events in the future.  

At the launch, we heard from Dr. Antonio Gargiulo, a medical professor at Harvard University. He spoke about how “reproductive failure is a growing health crisis.” He recently began to offer immunological assessments and treatments to his patients with great success. According to Dr. Gargiulo, “the immune system is central to pregnancy, and when we treat fertility patients, we can no longer ignore reproductive immunology.”

After Dr. Gargiulo’s talk, we heard from Dr. Andrea Vidali, CEO of Pregmune. He explained why he founded Pregmune and “created IRMA to help simplify and expand access to reproductive immunology testing and treatments.” Dr. Vidali then walked us through an IRMA report and showed us how it has been used successfully in his clinic to help more than a thousand hopeful patients. 

“Reproductive failure is a growing health crisis. The immune system is central to pregnancy, and when we treat fertility patients, we can no longer ignore reproductive immunology.”

– Antonio Gargiulo, MD 

What is IRMA?

IRMA, Pregmune’s first offering, is an AI-powered fertility assessment that guides physicians and their patients through a comprehensive reproductive immunology evaluation. We make it easy to order 55 informative blood tests, then we analyze the test results and present the findings in an easy-to-read, patient-friendly report that includes intuitive visuals and a results-based treatment plan recommendation.